par Pirson, Magali
;Sophie, Marbaix;Bruyneel, Arnaud
;Leclercq, Pol
;van den bulcke, julie
;Jonathan, Brauner
Référence Vaccine, 42, 12, page (3018-3023)
Publication Publié, 2024-04-01




Référence Vaccine, 42, 12, page (3018-3023)
Publication Publié, 2024-04-01
Article révisé par les pairs
Résumé : | pneumococcal infections are associated with high morbidity, hospitalisation and mortality. The objective of this study was to investigate the health and economic burden of all-cause pneumonia and invasive pneumococcal disease in Belgian hospital settings, by patient's age and risk profile. |